Sunwin International Neutraceuticals Posts Financial Performance for 3rd Quarter of Fiscal 2006. Achieves Record Growth in Revenues and Earnings, EPS of 0.02
Fort Lauderdale, FL and Qufu, China, March 17, 2005 (M2 PRESSWIRE) ¨C Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, posted financial results for the third quarter ended January 31, 2006 of fiscal year 2006.
The Company recorded revenues of $3.841 million for the third quarter ended January 31, 2006; a 42% increase from $2.705 million recorded for the same period in fiscal 2005. Net income surged to approximately $877,588, a 350% increase over the $193,698 in net income reported for the same period in fiscal year 2005. This translates to an EPS of $0.02 for the third quarter. For more details about Sunwin¡¯s financial performance, please review the 10-QSB filed with the United States Securities and Exchange Commission.
As of the third quarter of the fiscal year 2006, the Company had in excess of $3.6 million in cash and cash equivalents. Shareholder equity increased to $10.355 million, its highest level ever, a 125% increase from $4.552 million recorded for the same period in fiscal year 2005.
Laiwang Zhang, Chairman and President of Sunwin, commented, "We are very pleased with our financial performance in the third quarter for fiscal 2006. While we expect to maintain our recent growth in revenues and earnings in our core businesses, we will continue to evaluate new acquisition candidates. Our growth strategy will include both internal growth and external acquisitions in the coming fiscal quarters. Management is very optimistic about our prospects, as we expect to substantially increase our sales and profit margins in all of the three divisions in the coming fiscal years.¡±
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. (¡°Sunwin¡±, OTCBB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevioside), and animal medicine prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumer to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit http://www.sunwin.biz
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.
Contact:
Jimmy Glickstein
Tel: 561-989-3286
Email: info@sunwin.biz
Disclaimer: All statements and expressions are the sole opinions of the editors and are subject to change without notice. A description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
China Direct Investments, Inc. ("CDI") is not a Registered Investment Advisor or a Broker/Dealer. The information that we provide is not a solicitation to buy or sell securities. We do not provide investment advice or make investment recommendations of any of the companies we discuss. We do not recommend the purchase or sale of any company whose stock it profiles, nor does the discussion of any company constitute a recommendation to purchase or sell the companies shares.
CDI does not warrant or make any representations regarding the use of or the results of the use of the materials on this web site in terms of their correctness, accuracy, reliability, profit or otherwise. Past performance is not necessarily an indication of future performance. CDI makes no representation that any account will, or is likely to achieve profits or losses similar to those shown.
Investing in securities is speculative and may carry a high degree of risk. As a reader of our newsletter, you will be responsible for your own trading and investment decisions. You have to set your own goals whether you want to invest for short or long term. We are not responsible for your investment decision. We give you ideas, stock picks, and buy alert to work with. We advise you do research yourself to make a proper investment decision depending on your own risk objectives.
The information set forth herein is obtained from sources believed reliable, but we do not guarantee its accuracy or completeness. Investors are urged to obtain information directly from the company to further add to their investment decision. This information is provided for informational purpose only and without warranty of any kind. CDI is not liable for any investment decision made. We may have stock positions on profiled companies from time to time and receive consulting fees/compensation for profiled companies. We may profit in the event the shares of the Company profiled by us increase in value. These positions may be liquidated from time to time even after we have made positive comments regarding the Company. The receipt of this information constitutes your acceptance of these terms and conditions.
Safe Harbor Statement: Certain statements set forth in this newsletter constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets.
--------------------------------------------------
Unsubscribe: http://ymlp.com/u.php?chinadirect+sergev@pt.lu
Hosting by YourMailingListProvider
|
Thread abonnieren
ETF-Sparplan